Neurological Involvement as a Manifestation of Brucellosis Infection:

a case report

  • José Emilio Salazar Vaz Instituto de Neurología. Hospital de Clínicas Dr. Manuel Quintela. Universidad de la República. Montevideo. Uruguay.
  • Steven Tapia-Villacis Unidad Académica de Enfermedades Infecciosas. Hospital de Clínicas. Universidad de la República, Montevideo. Uruguay.
  • Fabián Gómez Instituto de Neurología. Hospital de Clínicas Dr. Manuel Quintela. Universidad de la República. Montevideo. Uruguay.
  • Adriana Pisani Departamento de Salud Ocupacional. Hospital de Clínicas Dr. Manuel Quintela. Universidad de la República. Montevideo. Uruguay.
  • Victoria Frantchez Unidad Académica de Enfermedades Infecciosas. Hospital de Clínicas. Universidad de la República, Montevideo. Uruguay.
Keywords: Neurobrucellosis, Brucella abortus, Optic Neuropathy, Hearing Loss, Sensorineural, Zoonoses

Abstract

Introduction: Neurobrucellosis is a rare complication of brucellosis, accounting for 3–5% of cases and may present with a wide range of neurological manifestations. Diagnosis is often challenging due to nonspecific clinical findings and the low sensitivity of conventional microbiological methods.
Case report: We describe a 26-year-old male with type 1 diabetes mellitus and occupational exposure to cattle who presented with progressive, painless bilateral visual loss. During follow-up, he developed bilateral sensorineural hearing loss. Neuroimaging was normal, and serology was positive for Brucella abortus (IgG positive, IgM negative, agglutination 1:320). Cerebrospinal fluid analysis and genetic testing for alternative causes were negative. The patient received combination therapy with doxycycline,
rifampicin, and trimethoprim-sulfamethoxazole for six months, achieving complete recovery of visual and auditory function.

Discussion: The coexistence of optic and auditory neuropathy in a patient with metabolic and occupational risk factors represents an uncommon form of neurobrucellosis. Clinical–serological correlation and prolonged combined antibiotic therapy are essential for accurate diagnosis and management.
Conclusion: This case underscores the importance of considering neurobrucellosis in patients with atypical neurological manifestations and of initiating early, prolonged, and combined antimicrobial therapy to prevent relapse and neurological sequelae.

Downloads

Download data is not yet available.

References

Qureshi KA, Parvez A, Fahmy NA, Hady BHA, Kumar S, Ganguly A, et al. Brucellosis: epidemiology, pathogenesis, diagnosis and treatment – a comprehensive review. Ann Med. 2023;55(2). https://doi.org/10.1080/07853890.2023.2295398

Laine CG, Johnson VE, Scott H, Arenas-Gamboa ÁM. Global estimate of human brucellosis incidence. Emerg Infect Dis. 2023;29(9). https://doi.org/10.3201/eid2909.230052

Pereira CRC, Almeida JVFC, Oliveira IRC, Oliveira LF, Pereira LJ, Zangerônimo MG, et al. Occupational exposure to Brucella spp.: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2020;14(5):e0008164. https://doi.org/10.1371/journal.pntd.0008164

Pisani A. Estudio de 14 casos de brucelosis en trabajadores de un frigorífico como enfermedad profesional. Uruguay 2009–2010. Rev Med Urug. 2017;33(3):168-73. https://doi.org/10.29193/rmu.33.3.1

Moreno E, Barquero-Calvo E. The role of neutrophils in brucellosis. Microbiol Mol Biol Rev. 2020;84(4). https://doi.org/10.1128/mmbr.00048-20

Bouferraa Y, Bou Zerdan M, Hamouche R, Azar E, Afif C, Jabbour R. Neurobrucellosis: brief review. Neurologist. 2021;26(6):248-52. https://doi.org/10.1097/NRL.0000000000000348

Kacem I, Mrabet S, Gargouri-Berrechid A, Ben Djebara M. Neurobrucellose. EMC Neurol. 2018;1-10. https://doi.org/10.1016/S0246-0378(17)79772-2

Gül HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. 2009;13(6):e339-43. https://doi.org/10.1016/j.ijid.2009.02.015

Tajerian A, Sofian M, Zarinfar N, Ramezani A. Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis. 2022. https://doi.org/10.21203/rs.3.rs-1424537/v1

Yagupsky P, Morata P, Colmenero J. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33(1). https://doi.org/10.1128/cmr.00073-19

Soares CN, Angelim AIM, Brandão CO, Santos RQ, Mehta R, Silva MTT. Neurobrucellosis: the great mimicker. Rev Soc Bras Med Trop. 2022;55:e05672021. https://doi.org/10.1590/0037-8682-0567-2021

Ceran N, Turkoglu R, Erdem I, Inan A, Engin D, Tireli H, et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Braz J Infect Dis. 2011;15(1):52-9. https://doi.org/10.1016/s1413-8670(11)70140-4

Rodríguez AM, Delpino MV, Miraglia MC, Giambartolomei GH. Immune mediators of pathology in neurobrucellosis: from blood to central nervous system. Neuroscience. 264-273. https://doi.org/10.1016/j.neuroscience.2019.05.018

Zhang X, Yao X, Chen H, Han D, Yang M. Meta-genomic next-generation sequencing in the diagnosis of brucellosis: five cases from a non-endemic area. Future Microbiol. 2024;19(13):1111-7. https://doi.org/10.1080/17460913.2024.2363632

Liu H, Li Q, Ouyang X, Li Q, Yu M, Dai L. Diagnosis of early neurobrucellosis using metagenomic next-generation sequencing of cerebrospinal fluid in a non-epidemic zone: case report and literature review. Medicine (Baltimore). 2025;104(7):e41481. https://doi.org/10.1097/md.0000000000041481

Published
2026-01-21
How to Cite
Salazar Vaz, J. E., Tapia-Villacis, S., Gómez, F., Pisani, A., & Frantchez, V. (2026). Neurological Involvement as a Manifestation of Brucellosis Infection: : a case report. Anales De La Facultad De Medicina, 13(1), e401. https://doi.org/10.25184/anfamed2026v13n1a2